MEMTAB 2025: "Methodology That Stands the Test

MEMTAB is the leading international conference about methods to evaluate models, tests & biomarkers for healthcare. It allows debate & dissemination of best methods for developing, evaluating & identifying reliable models, tests & biomarkers for use in clinical practice​​. 

In 2025, for our 7th International conference, we return to the University of Birmingham and raise the conference theme:​ "Methodology That Stands the Test”.

We want participants to push our understanding of what constitutes the research evidence needed for models, tests and biomarkers to be reliably endorsed, communicated and deployed in practice.

Details:

Tuesday 29 April: pre-conference courses, followed by a welcome reception 

(pre-conference courses to be booked separately at an additional fee)

Wednesday 30 April: conference day 1, followed by an evening meal and entertainment

Thursday 1 May: conference day 2

Location:

Alan Walters building, University of Birmingham (main campus), Edgbaston, UK.

Content:

The conference focuses on methodology for models, tests and biomarkers.

Topics of interest include (but are not limited to):

- screening and early diagnosis
- emerging technologies including multi-condition tests and self-tests
- evaluation, regulation and implementation
- education and communication, including to policy makers, patients and public
- examining and improving fairness and generalisability
- quantifying uncertainty and handling different types of variability
- clinical pathways for diagnosis, prognosis and monitoring
- impact assessment and monitoring strategies
- patient & public involvement and engagement (PPIE) in methods research
- study design (including sample size, sources of data, reporting)
- novel approaches including AI, machine learning, decision analytics & counterfactual prediction
- early-phase research
- systematic reviews & meta-analyses, especially using individual participant data
- health economics and decision analysis

 Registration, and Abstract Submission are now open!